You just read:

Intezyne Technologies Initiates First-In-Human Trials for Topoisomerase-1 Inhibitor IT-141; GRP78 Inhibitor IT-139 to be Featured in AACR Symposium

News provided by

Intezyne Technologies, Inc.

Mar 31, 2017, 14:13 ET